pharma news today glp-1 obesity drugs today Therapies Drive Indian Growth | Mohd Umar posted on the topic Market Overview: GLP-1 Agonists and

Hympavzi was approved only for hemophilia A and B patients without inhibitors, but Pfizer is expecting data on Hympavzi in patients with inhibitors next year that could support a label expansion, Endpoints News reported

There is no large, blinded, placebo-controlled human trial of BPC-157 for any indication

If you assume a 50% price erosion, Canada and Brazil can add about $500 million in terms of the generic market value, he said

Severity Of Condition: The severity and depth of discolouration can directly determine the cost

Neova DNA Repair Factor Nourishing Lotion Stimulates Collagen and Speeds Natural Repair Process

ELISA assay finally requires for enzyme-catalyzed substrate to complete the staining reaction